We are live on ! Find out more
Globeflex Capital

Globeflex Capital Portfolio holdings

AUM $783M Turnover 28.73%
1-Year Est. Return 81.58%
This Fund
S&P 500
This Quarter Est. Return
+34.81%
1 Year Est. Return
+81.58%
3 Year Est. Return
+185.88%
5 Year Est. Return
+280.02%
10 Year Est. Return
+1,365.88%
AUM
$783M
AUM Growth
+$122M
Cap. Flow
-$22.1M
Cap. Flow %
-2.82%
Top 10 Hldgs %
18.08%
Holding
456
New
69
Increased
67
Reduced
73
Closed
62
Avg Time Held
1.9 years
Top 10 Avg Time Held
0.5 years
Top 20 Avg Time Held
0.4 years

Top Buys

Rank Stock Value
1
CIEN icon
Ciena
CIEN
+$6.96M
2
MYRG icon
MYR Group
MYRG
+$4.57M
3
DRS icon
Leonardo DRS
DRS
+$4.16M
4
SMTC icon
Semtech
SMTC
+$3.99M
5
P icon
Everpure Inc
P
+$3.43M

Sector Composition

Rank Sector Weight
1 Technology 27.29%
2 Industrials 19.78%
3 Financials 17.73%
4 Healthcare 17.14%
5 Consumer Discretionary 7.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
OPFI icon
76
OppFi
OPFI
$479M
$3.24M 0.41%
326,313
-8,128
-2% -$70.3K
2024 Q3
7 quarters
KE icon
77
Kimball Electronics
KE
$620M
$3.21M 0.41%
125,262
– –
2025 Q3
3 quarters
CMCL icon
78
Caledonia Mining Corp
CMCL
$392M
$3.12M 0.4%
163,383
– –
2024 Q4
6 quarters
IBEX icon
79
IBEX
IBEX
$597M
$3.11M 0.4%
102,475
– –
2022 Q2
16 quarters
PBYI icon
80
Puma Biotechnology
PBYI
$539M
$3.1M 0.4%
382,807
+33,156
+9% +$243K
2020 Q2
24 quarters
ALNT icon
81
Allient
ALNT
$1.46B
$2.87M 0.37%
27,920
-13,912
-33% -$1.07M
2024 Q4
6 quarters
DFIN icon
82
Donnelley Financial Solutions
DFIN
$1.63B
$2.87M 0.37%
68,494
– –
2021 Q1
21 quarters
BAND icon
83
Bandwidth Inc
BAND
$1.53B
$2.87M 0.37%
45,268
-15,815
-26% -$710K
2024 Q3
7 quarters
ZWS icon
84
Zurn Elkay Water Solutions
ZWS
$7.4B
$2.85M 0.36%
56,336
+339
+0.6% +$16.6K
2024 Q1
9 quarters
PARR icon
85
Par Pacific Holdings
PARR
$3.82B
$2.8M 0.36%
50,010
– –
2022 Q4
14 quarters
GOLD icon
86
Gold.com Inc
GOLD
$1.11B
$2.78M 0.36%
66,876
-1,897
-3% -$81.6K
2025 Q3
3 quarters
CW icon
87
Curtiss-Wright
CW
$17.6B
$2.77M 0.35%
3,650
-46
-1% -$33.7K
2024 Q1
9 quarters
ZVRA icon
88
Zevra Therapeutics
ZVRA
$610M
$2.75M 0.35%
+191,904
New +$2.13M
2026 Q2
0 quarters
AXGN icon
89
Axogen
AXGN
$2.95B
$2.7M 0.35%
58,497
– –
2024 Q3
7 quarters
KLAC icon
90
KLA
KLAC
$206B
$2.63M 0.34%
8,710
– –
2025 Q2
4 quarters
JAZZ icon
91
Jazz Pharmaceuticals
JAZZ
$14B
$2.57M 0.33%
10,645
+51
+0.5% +$11.2K
2025 Q4
2 quarters
AMRX icon
92
Amneal Pharmaceuticals
AMRX
$7.49B
$2.54M 0.32%
146,508
+205
+0.1% +$2.81K
2020 Q1
25 quarters
AIR icon
93
AAR Corp
AIR
$4.03B
$2.51M 0.32%
17,531
+669
+4% +$79K
2025 Q4
2 quarters
APEI icon
94
American Public Education
APEI
$742M
$2.5M 0.32%
46,510
+6,796
+17% +$373K
2025 Q1
5 quarters
HOV icon
95
Hovnanian Enterprises
HOV
$592M
$2.5M 0.32%
17,534
– –
2024 Q1
9 quarters
ATEN icon
96
A10 Networks
ATEN
$1.78B
$2.44M 0.31%
65,303
– –
2020 Q3
23 quarters
DRH icon
97
Diamondrock Hospitality Co
DRH
$2.92B
$2.39M 0.31%
+196,402
New +$2.14M
2026 Q2
0 quarters
MOG.A icon
98
Moog Inc Class A
MOG.A
$11.1B
$2.39M 0.3%
5,629
-41
-0.7% -$14K
2026 Q1
1 quarter
CSCO icon
99
Cisco
CSCO
$412B
$2.35M 0.3%
20,040
– –
2023 Q1
13 quarters
WT icon
100
WisdomTree
WT
$3.13B
$2.31M 0.3%
136,640
+93
+0.1% +$1.65K
2024 Q2
8 quarters

Similar funds

Globeflex Capital's Q2 2026 Portfolio in Review

As of Q2 2026, Globeflex Capital held 456 positions worth $783M, up 18% from $661M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Globeflex Capital's Q2 2026 filing shows 69 new, 67 increased, 73 reduced and 62 closed positions. Its largest new stake was Ciena: 13,648 shares worth $6.7M. The largest sale was Catalyst Pharmaceutical, an estimated $11.2M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Industrials and Financials.

  • Globeflex Capital's largest Q2 2026 buy was Ciena: 13,648 shares worth $6.7M.
  • Globeflex Capital added most to MYR Group in Q2 2026, an estimated $4.57M increase.
  • Globeflex Capital's biggest Q2 2026 reduction was Rigel Pharmaceuticals, cutting an estimated $3.24M.
  • Globeflex Capital fully exited Catalyst Pharmaceutical in Q2 2026, selling an estimated $11.2M.
  • Globeflex Capital's ten largest holdings make up 18% of its $783M portfolio in Q2 2026.
  • Globeflex Capital opened 69 new positions and closed 62 in Q2 2026.
  • Globeflex Capital's portfolio value rose 18% quarter-over-quarter to $783M.

Based on Globeflex Capital's 13F filing for Q2 2026, filed 12 Aug 2026.